<SEC-DOCUMENT>0001140361-20-018599.txt : 20200817
<SEC-HEADER>0001140361-20-018599.hdr.sgml : 20200817
<ACCEPTANCE-DATETIME>20200817165841
ACCESSION NUMBER:		0001140361-20-018599
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200811
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200817
DATE AS OF CHANGE:		20200817

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARYA Sciences Acquisition Corp III
		CENTRAL INDEX KEY:			0001808805
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39434
		FILM NUMBER:		201110952

	BUSINESS ADDRESS:	
		STREET 1:		51 ASTOR PLACE, 10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10003
		BUSINESS PHONE:		2122842300

	MAIL ADDRESS:	
		STREET 1:		51 ASTOR PLACE, 10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10003
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nc10014473x1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"><font style="font-size: 14pt;">SECURITIES AND
        EXCHANGE COMMISSION</font></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div>
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM 8-K</div>
    <div>
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">CURRENT REPORT</div>
    <div style="text-align: center;">Pursuant to Section 13 or 15(d)</div>
    <div style="text-align: center;">of the Securities Exchange Act of 1934</div>
    <div style="text-align: center;">Date of Report (Date of Earliest Event Reported): August 11, 2020</div>
    <div>
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
    <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
    <div>
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd0664b3de7df4a30b23b0a1725a6af26" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 32.99%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">Cayman Islands</div>
            <div style="text-align: center;">(State or other jurisdiction of incorporation or organization)</div>
          </td>
          <td style="width: 34%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">001-39434</div>
            <div style="text-align: center; font-weight: bold;">(Commission File Number)</div>
          </td>
          <td style="width: 33%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">98-1541723</div>
            <div style="text-align: center;">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 32.99%; vertical-align: bottom;">&#160;</td>
          <td rowspan="1" style="width: 34%; vertical-align: bottom;">&#160;</td>
          <td rowspan="1" style="width: 33%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 32.99%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">51 Astor Place, 10th Floor</div>
            <div style="text-align: center; font-weight: bold;">New York, New York</div>
            <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
          </td>
          <td style="width: 34%; vertical-align: bottom;">&#160;</td>
          <td style="width: 33%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">10003</div>
            <div style="text-align: center; font-weight: bold;">(Zip Code)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">(212) 284-2300</div>
    <div style="text-align: center; font-weight: bold;">Registrant&#8217;s telephone number, including area code</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Not Applicable</div>
    <div style="text-align: center; font-weight: bold;">(Former name or former address, if changed since last report)</div>
    <div>
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:</div>
    <div><br>
    </div>
    <div>&#9744; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
    <div>&#9744; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
    <div>&#9744; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
    <div>&#9744; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
    <div><br>
    </div>
    <div>Securities registered pursuant to Section 12(b) of the Act:</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z51462deccc9f4cb2977a40a7fba1f7c9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 55.56%; vertical-align: bottom; border-right: #000000 2px solid; border-top: #000000 4px double;">
            <div style="text-align: center; font-weight: bold;">Title of each class</div>
          </td>
          <td style="width: 17.59%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 4px double;">
            <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
          </td>
          <td style="width: 26.85%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 4px double;">
            <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 55.56%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div>Class A Ordinary Shares, par value $0.0001 per Share</div>
          </td>
          <td style="width: 17.59%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">ARYA</div>
          </td>
          <td style="width: 26.85%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">The Nasdaq Capital Market</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</div>
    <div><br>
    </div>
    <div>Emerging growth company &#9746;</div>
    <div><br>
    </div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
      Act. &#9744;
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <font style="font-weight: bold;">Item 8.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Entry into a Material Definitive Agreement.</font>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">On August 11, 2020, ARYA Sciences Acquisition Corp III (the &#8220;Company&#8221;) consummated an initial public offering (the &#8220;IPO&#8221;) of 14,950,000 Class A ordinary shares (the &#8220;Shares&#8221;), including the 1,950,000 Shares as a result
      of the underwriters&#8217; full exercise of their over-allotment option, at an offering price of $10.00 per Share and a private placement with ARYA Sciences Holdings III of 499,000 Class A ordinary shares (the &#8220;Private Placement&#8221;). The net proceeds from
      the IPO, together with certain of the proceeds from the Private Placement, $149,500,000 in the aggregate (the &#8220;Offering Proceeds&#8221;), were placed in a trust account established for the benefit of the Company&#8217;s public shareholders and the underwriters
      of the IPO with Continental Stock Transfer &amp; Trust Company acting as trustee. Except with respect to interest earned on the Offering Proceeds held in the trust account that may be released to the Company to pay its income taxes, if any, the
      Company&#8217;s amended and restated memorandum and articles of association will provide that the Offering Proceeds will not be released from the trust account (1) to the Company, until the completion of its initial business combination, or (2) to its
      public shareholders, until the earliest of (a) the completion of the its initial business combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to certain limitations,
      (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company&#8217;s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company&#8217;s obligation to
      provide holders of its Class A ordinary shares the right to have their shares redeemed in connection with the Company&#8217;s initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business
      combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to the rights of holders of its Class A ordinary shares, and (c) the redemption of the public shares if the Company has not consummated its
      business combination within 24 months from the closing of the IPO, subject to applicable law.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">An audited balance sheet as of August 11, 2020 reflecting receipt of the Offering Proceeds has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Item 9.01.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Financial Statements and Exhibits.</font></div>
    <div><br>
    </div>
    <div style="font-weight: bold;">(d) Exhibits</div>
    <div><br>
    </div>
    <div><a href="nc10014473x1_ex99-1.htm">99.1</a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Audited Balance Sheet</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div style="text-indent: 35.95pt; margin-left: 6pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>
    &#160;&#160; <br>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbb2a04fcb94542ea943de4501d46bb90" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;Date: August 17, 2020</td>
          <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">ARYA SCIENCES ACQUISITION CORP III&#160; <br>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>By:</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
            <div>/s/ Adam Stone</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>Name:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div>Adam Stone</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>Title:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div>Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>nc10014473x1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div>
      <div style="text-align: right; font-weight: bold;">
        <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 99.1</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
      <div><br>
      </div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2ee294d999df4e45af77a9c68dc2db3f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 95%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">Report of Independent Registered Public Accounting Firm</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">F-2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95%; vertical-align: bottom;">
            <div style="text-align: justify;">Balance Sheet</div>
          </td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-align: justify;">F-3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">Notes to Balance Sheet</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">F-4</div>
          </td>
        </tr>

    </table>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%F-%%-->
    <div style="text-align: center; font-weight: bold;">Report of Independent Registered Public Accounting Firm</div>
    <div><br>
    </div>
    <div>To the Shareholders and the Board of Directors of</div>
    <div>ARYA Sciences Acquisition Corp. III</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Opinion on the Financial Statement</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We have audited the accompanying balance sheet of ARYA Sciences Acquisition Corp. III (the &#8220;Company&#8221;) as of August 11, 2020 and the related notes (collectively referred to as the &#8220;financial statement&#8221;). In our opinion,
      the financial statement presents fairly, in all material respects, the financial position of the Company as of August 11, 2020 in conformity with accounting principles generally accepted in the United States of America.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Basis for Opinion</div>
    <div><br>
    </div>
    <div style="text-align: justify;">This financial statement is the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statement based on our audit. We are a public accounting firm
      registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
      Securities and Exchange Commission and the PCAOB.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statement is free of material
      misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal
      control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Our audit included performing procedures to assess the risks of material misstatement of the financial statement, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
      included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statement. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the
      overall presentation of the financial statement. We believe that our audit provides a reasonable basis for our opinion.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">&#160;/s/ WithumSmith+Brown, PC</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We have served as the Company&#8217;s auditor since 2020.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">New York, New York</div>
    <div style="text-align: justify;">August 17, 2020</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
    <div style="text-align: center; font-weight: bold;">BALANCE SHEET</div>
    <div style="text-align: center; font-weight: bold;">August 11, 2020</div>
    <div><br>
    </div>
    <table id="z7ece49ac8cb6483e9e2d467ed40da49c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="vertical-align: middle;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Assets:</div>
          </td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: middle;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle;" nowrap="nowrap" valign="bottom">
            <div>Current assets:</div>
          </td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: middle;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="text-indent: 20pt;">Cash</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>1,392,938</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">
            <div style="text-indent: 20pt;">Prepaid expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">
            <div>374,203</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total current assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>1,767,141</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">
            <div>Cash held in Trust Account</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">
            <div>149,500,000</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">151,267,141</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Liabilities and Shareholders&#8217; Equity:</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" nowrap="nowrap" valign="bottom">
            <div>Current liabilities:</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="text-indent: 20pt;">Accounts payable</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>395</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">
            <div style="text-indent: 20pt;">Accrued expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">
            <div>320,000</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total current liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>320,395</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">
            <div>Deferred underwriting commissions</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">
            <div>5,232,500</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>5,552,895</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Commitments and Contingencies</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" valign="bottom">
            <div>Class A ordinary shares, $0.0001 par value; 14,071,424 shares subject to possible redemption at $10.00 per share</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">
            <div>140,714,240</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Shareholders&#8217; Equity:</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div>Preference shares, $0.0001 par value&#894; 1,000,000 shares authorized&#894; none issued and outstanding</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>-</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" valign="bottom">
            <div>Class A ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 1,377,576 shares issued and outstanding (excluding 14,071,424 shares subject to possible redemption)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">
            <div>138</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div>Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 3,737,500 shares issued and outstanding</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>374</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%;" valign="bottom">
            <div>Additional paid-in capital</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%;" nowrap="nowrap" valign="bottom">
            <div>5,045,067</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div>Accumulated deficit</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>(45,573</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total shareholders&#8217; equity</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap" valign="bottom">
            <div>5,000,006</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">Total Liabilities and Shareholders&#8217; Equity</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9.01%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="font-weight: bold;">151,267,141</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 0.97%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="text-align: center;">The accompanying notes are an integral part of the financial statement.</div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
    <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
    <div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 1 &#8212; Description of Organization and Business Operations</div>
      <div><br>
      </div>
      <div style="text-align: justify;">ARYA Sciences Acquisition Corp III (the &#8220;Company&#8221;) was incorporated as a Cayman Islands exempted company on March 27, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset
        acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with
        emerging growth companies.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">As of August 11, 2020, the Company had not commenced any operations. All activity for the period from March 27, 2020 (inception) through August 11, 2020 relates to the Company&#8217;s formation and the initial public
        offering (the &#8220;Initial Public Offering&#8221;) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the
        form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company&#8217;s sponsor is ARYA Sciences Holdings III, a Cayman Islands exempted limited company (the &#8220;Sponsor&#8221;).&#160; The registration statement for the Company&#8217;s Initial Public Offering was declared effective on August
        6, 2020.&#160; On August 11, 2020, the Company consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the &#8220;Public Shares&#8221;), including the 1,950,000 Public Shares as a result of the underwriters&#8217; full exercise of their
        over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.8 million, inclusive of approximately $5.2 million in deferred underwriting
        commissions (Note 5).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&#8220;Private Placement&#8221;) of 499,000 Class A ordinary shares (the &#8220;Private Placement Shares&#8221;), at a price of
        $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million (Note 4).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were
        placed in a trust account (&#8220;Trust Account&#8221;), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer &amp; Trust Company acting as trustee, and will be invested only in U.S. government securities, within the
        meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in money market fund meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as
        determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the
        net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial
        Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the
        Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the
        outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment
        Company Act&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company will provide the holders (the &#8220;Public Shareholders&#8221;) of Public Shares, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in
        connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be
        made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro
        rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the
        deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5).</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-4</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">These Public Shares are classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification
        (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only
        if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does
        not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering
        (the &#8220;Amended and Restated Memorandum and Articles of Association&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior to completing
        a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a
        proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or
        vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased
        during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from
        purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company&#8217;s legal counsel prior to execution. In addition, the initial shareholders have
        agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of a Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules,
        the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined
        under Section 13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public
        Offering, without the prior consent of the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company&#8217;s Sponsor, officers and directors (the &#8220;initial shareholders&#8221;) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the
        substance or timing of the Company&#8217;s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company&#8217;s Public Shares if the Company does not
        complete its Business Combination within 24 months from the closing of the Initial Public Offering, or August 11, 2022 (the &#8220;Combination Period&#8221;) or with respect to any other provision relating to the rights of Public Shareholders, unless the
        Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not
        more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not
        previously released to the Company to pay for its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public
        Shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining shareholders
        and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-5</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the
        Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company
        fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a
        Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such
        distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the
        Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering
        into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
        Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in
        or to any monies held in the Trust Account or to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the
        &#8220;Securities Act&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will
        seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company&#8217;s independent registered public accounting firm),
        prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic;">Liquidity and Capital Resources</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify;">As of August 11, 2020, the Company had approximately $1.4 million in its operating bank account, and working capital of approximately $1.4 million.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify;">The Company&#8217;s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, the loan proceeds of
        $200,000 from the Sponsor pursuant to the Note (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on August 11, 2020.&#160; In addition, in order to finance
        transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of
        August 11, 2020, there were no amounts outstanding under any Working Capital Loan.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and
        directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and
        evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and
        consummating the Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statement does not
        include any adjustments that might result from the outcome of this uncertainty.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-6</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 2 &#8212; Summary of Significant Accounting Policies</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Basis of Presentation</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The accompanying balance sheet is presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the
        SEC.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Emerging Growth Company</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private
        companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
        standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable.
        The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can
        adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statement with another public company that is neither an emerging growth company nor an emerging
        growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Concentration of Credit Risk</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage
        of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Cash and Cash Equivalents</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of August 11, 2020.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Financial Instruments</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the
        balance sheet.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Use of Estimates</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The preparation of financial statement in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of
        contingent assets and liabilities at the date of the balance sheet.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Offering Costs Associated with the Initial Public Offering</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to shareholders&#8217; equity upon the completion of
        the Initial Public Offering.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Class A ordinary shares subject to possible redemption</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;<font style="font-style: italic;">Distinguishing Liabilities from Equity</font>.&#8221;
        Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at redemption value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature
        redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, Class A ordinary
        shares are classified as shareholders&#8217; equity. The Company&#8217;s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly,
        at August 11, 2020, 14,071,424 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance sheet.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-7</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Income Taxes</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences
        attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
        income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date.
        Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits
        to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of August 11, 2020. The Company&#8217;s management determined that the Cayman Islands is the
        Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the period from March 27,
        2020 (inception) through August 11, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations
        by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently,
        income taxes are not reflected in the Company&#8217;s financial statements. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Recent Accounting Pronouncements</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 3 &#8212; Initial Public Offering</div>
      <div><br>
      </div>
      <div style="text-align: justify;">On August 11, 2020, the Company consummated its Initial Public Offering of 14,950,000 Public Shares, including the 1,950,000 Public Shares as a result of the underwriters&#8217; full exercise of their over-allotment
        option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.8 million, inclusive of approximately $5.2 million in deferred underwriting commissions</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 4 &#8212; Related Party Transactions</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Founder Shares</div>
      <div><br>
      </div>
      <div style="text-align: justify;">On April 2, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 3,593,750 Class B ordinary shares, par value $0.0001, (the &#8220;Founder Shares&#8221;). In July 2020, the Sponsor
        transferred an aggregate of 90,000 Founder Shares to the Company&#8217;s independent director nominees. On August 6, 2020, the Company effected a share capitalization resulting in the initial shareholders holding 3,737,500 Founder Shares. All shares and
        the associated amounts have been retroactively restated to reflect the share capitalization. The Sponsor agreed to forfeit up to 487,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so
        that the Founder Shares would represent 20.0% of the Company&#8217;s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering.&#160; The underwriters fully exercised the over-allotment option on August
        11, 2020; thus, these 487,500 Founder Shares were no longer subject to forfeiture.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-8</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business
        Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company&#8217;s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations,
        recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange,
        reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Private Placement Share</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor,
        generating gross proceeds of approximately $5.0 million.&#160; The Private Placement Shares will not be transferable or salable until 30 days after the completion of the initial Business Combination.&#160; A portion of the proceeds from the Private Placement
        Shares was added to the proceeds from the Initial Public Offering held in the Trust Account.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Sponsor and the Company&#8217;s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial
        Business Combination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Related Party Loans</div>
      <div><br>
      </div>
      <div style="text-align: justify;">On April 2, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). This loan was
        non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $200,000 under the Note and fully repaid this Note on August 11, 2020.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated
        to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise,
        the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working
        Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with
        respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1.5 million of such Working Capital Loans may be convertible into shares
        of the post Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. To date, the Company had no outstanding borrowings under the Working Capital Loans.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Administrative Support Agreement</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Commencing on the date that the Company&#8217;s securities are first listed on the Nasdaq through the earlier of consummation of the initial Business Combination and the Company&#8217;s liquidation, the Company will reimburse
        the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $10,000 per month.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Forward Purchase Arrangement</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Sponsor has indicated an interest to purchase up to an aggregate of $25 million of the Company&#8217;s ordinary shares in a private placement that would occur concurrently with the consummation of the initial Business
        Combination. However, because indications of interest are not binding agreements or commitments to purchase, the Sponsor may determine not to purchase any such shares, or to purchase fewer shares than it has indicated an interest in purchasing.
        Furthermore, the Company is not under any obligation to sell any such shares.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-9</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 5 &#8212; Commitments &amp; Contingencies</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Registration Rights</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The holders of Founder Shares, Private Placement Shares and Private Placement Shares that may be issued upon conversion of Working Capital Loans, will be entitled to registration rights pursuant to a registration and
        shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
        with respect to registration statements filed subsequent to the Company&#8217;s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed
        under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company&#8217;s initial shareholders entered into and (ii) in
        the case of the Private Placement Shares, 30 days after the completion of the Company&#8217; s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Underwriting Agreement</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments, at the Initial
        Public Offering price less the underwriting discounts and commissions.&#160; On August 11, 2020, the underwriters fully exercised the over-allotment option.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The underwriters were entitled to an underwriting discount of $0.20 per Public Share, or approximately $3.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per
        Public Share, or approximately $5.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in
        the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 6 &#8212; Shareholders&#8217; Equity</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold; font-style: italic;">Class A Ordinary Shares &#8212;</font> The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of August 11,
        2020, there were 15,449,000 Class A common shares outstanding, including 14,071,424 Class A common stock subject to possible conversion that were classified as temporary equity in the accompanying balance sheet.</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold; font-style: italic;">Class B Ordinary Shares &#8212;</font> The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On April 2, 2020, the
        Company issued 3,593,750 Class B ordinary shares. On August 6, 2020, the Company effected a share capitalization resulting in the initial shareholders holding 3,737,500 Founder Shares, of which up to 487,500 shares were subject to forfeiture to the
        Company by the Sponsor for no consideration to the extent that the underwriter&#8217;s over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company&#8217;s issued and outstanding ordinary
        shares (excluding the Private Placement Shares).&#160; All shares and the associated amounts have been retroactively restated to reflect the share capitalization.&#160; The underwriters fully exercised the over-allotment option on August 11, 2020; thus,
        these 487,500 Founder Shares were no longer subject to forfeiture.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders, except as required by law or stock
        exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company&#8217;s directors prior to the initial Business Combination and holders of a majority of the Company&#8217;s Class B ordinary shares
        may remove a member of the board of directors for any reason.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-10</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div>
        <div style="text-align: center; font-weight: bold;">ARYA SCIENCES ACQUISITION CORP III</div>
        <div style="text-align: center; font-weight: bold;">NOTES TO FINANCIAL STATEMENT</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A
        ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares) upon
        the consummation of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by
        the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed
        issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Shares issued to the Sponsor, members of the Company&#8217;s management team or any of their affiliates upon conversion of Working Capital Loans. In no
        event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to one.</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-weight: bold; font-style: italic;">Preference Shares &#8212;</font> The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share and with such designations, voting
        and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. As of August 11, 2020, there were no preference shares issued or outstanding.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-weight: bold;">Note 7 &#8212; Subsequent Events</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Management has evaluated subsequent events to determine if events or transactions occurring after the balance sheet date through August 17, 2020, the date the balance sheet was available for issuance, require
        potential adjustment to or disclosure in the financial statement and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed.</div>
    </div>
    <div><br>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F-11</font>
    <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
